AstraZeneca · conference-presentation
AstraZeneca | Results Presentation Deck | 157 slides
132 pages · 3 arc beats · 2 loops
AstraZeneca | Results Presentation Deck | 157 slides
AstraZeneca · 2024-11 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
1102030405060708090100110120130132
Deck intelligence map
3 coverage by narrative range · generated from this deck JSON
Narrative range 125 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 5 slides 100% 5/5 slides 100% 5/5 slides · 22 hits — 0/5 slides
20% 1/5 slides 40% 2/5 slides 100% 5/5 slides — 0/5 slides
Solution 115 slides 100% 115/115 slides 100% 115/115 slides · 350 hits — 0/115 slides
51.3% 59/115 slides 1.7% 2/115 slides 100% 115/115 slides 19.1% 22/115 slides Market Size 5 slides 100% 5/5 slides 100% 5/5 slides · 22 hits — 0/5 slides
100% 5/5 slides — 0/5 slides
100% 5/5 slides — 0/5 slides
Slide inventory
132 every slide · same image gating as the playbook
02
The slide uses a grid layout to present four key performance indicators related to the drug development pipeline.summarize
Open slide detailBeat · Problem
03
The slide uses a matrix-like layout to categorize events by time period and event type (regulatory vs. data readout).summarize
Open slide detailBeat · Problem
04
The slide uses a matrix-like layout to organize drug assets by therapeutic area and development stage (approved vs. pipeline).appendix
Open slide detailBeat · Problem
05
The slide uses a four-column layout to track drug development progress.summarize
Open slide detailBeat · Problem
06
The slide tracks changes in drug development pipeline status since the Q2 2024 update.summarize
Open slide detailBeat · Solution
07
The slide uses a grid-based layout to list specific drug assets and their indications within each phase column.summarize
Open slide detailBeat · Solution
08
The slide uses a grid-based layout to represent the drug development pipeline.summarize
Open slide detailBeat · Solution
09
The slide uses a grid-based layout to organize drug candidates by development stage. It includes a legend for '# Partnered and/or in collaboration' and a yellowother
Open slide detailBeat · Solution
10
The slide uses a timeline-like structure to categorize drug development projects by clinical phase.present_framework
11
The slide uses a Kanban-style board to visualize drug development stages.plan_implementation
12
The slide uses a color-coded system to distinguish between Oncology, Biopharmaceuticals, and Rare Disease designations.analyze_data
14
The slide uses a color-coded sidebar to indicate the development stage of the drug across different therapeutic areas.analyze_data
15
The slide provides a detailed overview of seven specific clinical trials (AEGEAN, ADJUVANT BR.31, PACIFIC-4, PACIFIC-5, PACIFIC-8, ADRIATIC, PACIFIC-9).analyze_data
16
The slide uses a standard clinical trial registry format.analyze_data
17
The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.analyze_data
18
The slide uses a standard clinical trial registry format.analyze_data
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.analyze_data
20
The slide is part of an appendix, likely from a pharmaceutical investor presentation.analyze_data
21
The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).analyze_data
Open slide detailBeat · Solution
22
The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.analyze_data
Open slide detailBeat · Solution
23
The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.analyze_data
Open slide detailBeat · Solution
24
The slide uses a standard clinical trial pipeline table format.analyze_data
Open slide detailBeat · Solution
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.analyze_data
Open slide detailBeat · Solution
26
The slide uses a standard clinical trial registry format for portfolio tracking.analyze_data
Open slide detailBeat · Solution
27
The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.analyze_data
Open slide detailBeat · Solution
28
The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).analyze_data
Open slide detailBeat · Solution
29
The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.analyze_data
Open slide detailBeat · Solution
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).analyze_data
31
The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).analyze_data
32
The slide is part of an appendix, indicated by the footer and the 'Appendix' label.analyze_data
33
The slide is part of an appendix, specifically detailing late-stage development assets in Oncology.appendix
34
The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.analyze_data
35
The slide is part of an appendix section, indicated by the page number and glossary link.analyze_data
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.analyze_data
37
The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).analyze_data
38
Includes trial identifiers (NCT numbers) and status timelines.analyze_data
39
The slide is an appendix page detailing clinical trial pipeline data for a specific drug.analyze_data
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).analyze_data
41
The slide is part of an appendix section detailing clinical trial pipelines.analyze_data
Open slide detailBeat · Solution
42
The slide is part of an appendix, specifically detailing late-stage development assets.analyze_data
Open slide detailBeat · Solution
43
The slide is part of an appendix, providing detailed clinical trial data for a specific asset.analyze_data
Open slide detailBeat · Solution
44
The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).analyze_data
Open slide detailBeat · Solution
45
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.analyze_data
Open slide detailBeat · Solution
46
The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.analyze_data
Open slide detailBeat · Solution
52
Part of a larger portfolio deck, indicated by the vertical navigation bar on the right.analyze_data
Open slide detailBeat · Solution
53
The slide is part of an appendix, providing detailed clinical trial data for a specific drug candidate.analyze_data
Open slide detailBeat · Solution
57
The slide provides a summary of two clinical trials (PRIMROSE and PRIMAVERA) including population, patient counts, design, endpoints, and status.analyze_data
Open slide detailBeat · Solution
58
Part of a corporate presentation appendix, specifically under the Oncology pipeline section.analyze_data
Open slide detailBeat · Solution
59
The slide uses a standard clinical trial table format common in pharmaceutical investor presentations.analyze_data
Open slide detailBeat · Solution
63
Part of a larger clinical pipeline deck; includes navigation sidebar for therapeutic areas.analyze_data
Open slide detailBeat · Solution
68
Part of an appendix detailing clinical pipeline assets.analyze_data
Open slide detailBeat · Solution
69
Part of a series of slides detailing clinical pipeline assets.analyze_data
Open slide detailBeat · Solution
70
Slide 70 of a larger deck, likely part of an appendix detailing clinical pipeline assets.summarize
Open slide detailBeat · Solution
72
The slide provides a structured overview of a single clinical trial (NCT05877599) including population, design, endpoints, and status.analyze_data
Open slide detailBeat · Solution
73
The slide uses a table format to summarize trial design, patient count, endpoints, and status for a specific clinical trial.analyze_data
Open slide detailBeat · Solution
74
The slide is part of an appendix, specifically detailing early development oncology assets.analyze_data
Open slide detailBeat · Solution
78
The slide provides a structured overview of three specific clinical trials (Balanced-HF, MIRACLE, MIRO-CKD).analyze_data
Open slide detailBeat · Solution
79
The slide is part of an appendix, indicated by the page number 79 and the 'Appendix' label at the bottom.analyze_data
Open slide detailBeat · Solution
80
The slide is part of an appendix, specifically detailing clinical trial data.analyze_data
Open slide detailBeat · Solution
82
The slide uses a vertical navigation bar on the right to indicate the therapeutic area (CVRM) and development stage (Late-stage development).analyze_data
Open slide detailBeat · Solution
83
The slide provides a structured summary of the ZEAL trial design, including population, arms, endpoints, and status.analyze_data
Open slide detailBeat · Solution
84
The slide uses a vertical tab structure on the right to categorize therapeutic areas, with 'R&I' highlighted.appendix
Open slide detailBeat · Solution
85
The slide uses a vertical tab structure on the right to categorize therapeutic areas, with 'R&I' highlighted.analyze_data
Open slide detailBeat · Solution
86
The slide is part of an appendix, indicated by the footer and the R&I tab selection.appendix
Open slide detailBeat · Solution
87
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
88
The slide provides a structured overview of clinical trial progress for a specific drug candidate.analyze_data
Open slide detailBeat · Solution
90
The slide is part of an appendix, indicated by the page number 90 and the 'Appendix: Glossary' footer.analyze_data
Open slide detailBeat · Solution
91
The slide includes a vertical navigation bar on the right indicating the therapeutic area 'Oncology' and a page number '91'.analyze_data
Open slide detailBeat · Solution
92
The slide uses a standard clinical trial registry format. The right-hand sidebar indicates the portfolio context (R&I).analyze_data
Open slide detailBeat · Solution
93
The slide includes a navigation sidebar on the right indicating 'Approved medicines' is the active category.analyze_data
Open slide detailBeat · Solution
94
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
95
The slide uses a vertical tab structure on the right to indicate the therapeutic area context (R&I).analyze_data
Open slide detailBeat · Solution
96
The slide includes a navigation sidebar on the right indicating the drug is in 'Late-stage development'.analyze_data
Open slide detailBeat · Solution
97
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
100
Slide 100 of a larger deck, likely part of a clinical pipeline appendix.appendix
Open slide detailBeat · Solution
101
The slide uses a standard clinical trial registry format for reporting pipeline status.analyze_data
Open slide detailBeat · Solution
102
The slide includes a vertical navigation bar on the right indicating the therapeutic area (Oncology, CVRM, R&I, Other, V&I, Rare Disease) and development stage analyze_data
Open slide detailBeat · Solution
104
The slide uses a standard clinical trial table format common in pharmaceutical investor presentations.analyze_data
Open slide detailBeat · Solution
105
The slide uses a vertical navigation bar on the right to indicate the development stage (Early development).analyze_data
Open slide detailBeat · Solution
106
The slide includes a vertical navigation bar on the right indicating the drug's development stage (Early development) and therapeutic area (CVRM).analyze_data
Open slide detailBeat · Solution
107
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
108
The slide is part of an appendix, providing specific trial data for a drug candidate.analyze_data
Open slide detailBeat · Solution
109
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.analyze_data
Open slide detailBeat · Solution
110
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
111
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
112
The slide uses a standard clinical trial registry format to detail study arms and timelines.analyze_data
Open slide detailBeat · Solution
113
The slide uses a standard clinical trial pipeline table format.analyze_data
Open slide detailBeat · Solution
115
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
116
The slide uses a standard clinical trial registry format.analyze_data
Open slide detailBeat · Solution
117
The slide includes a vertical navigation bar on the right indicating the therapeutic area (CVRM) and development stage (Early development).analyze_data
Open slide detailBeat · Solution
118
The slide uses a standard clinical trial table format.analyze_data
Open slide detailBeat · Solution
124
Includes a '25 years of pioneering science' anniversary badge.front_matter
Open slide detailBeat · Market Size